RCCA Gives Recognition to Governor Christie with 2013 Leadership Award
HACKENSACK, N.J., July 3, 2013 /PRNewswire/ -- Members of Regional Cancer Care Associates (RCCA), one of the nation's largest Oncology
cancer news and articles
from rcca
cancer news and articles
from rcca
We’re here for you. Call us at 844-346-7222 or
Results
U.S. Food and Drug Administration Approves REVLIMID® (lenalidomide).
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental
President Dr. Andrew Pecora Speaks at International Vatican Stem Cell Conference
Regional Cancer Care Associates’ President Dr. Andrew Pecora Speaks at International Vatican Stem Cell Conference Dr. Pecora Discussed Research and
Focusing on Clinical and Economic Outcomes – Not Guidelines
Is it Time for a New Direction in Oncology Care?
Dr. David Siegel featured in The Wall Street Journal
In case you missed it, two new drugs for multiple myeloma have been approved and are expected to extend life
24 RCCA Physicians Recognized as Top Doctors in 2012
Regional Cancer Care Associates (RCCA), the largest oncology physician network in New Jersey, is proud to announce that 31 RCCA
OncLive.com: Bending The Cost Curve
There was a time when biology, chemistry, and a little bit of physics led to dramatic changes in healthcare and
Oncology Business Review Interviews Dr. Andrew Pecora
OBR sits down with Dr. Andrew Pecora, President, Regional Cancer Care Associates to discuss the formation of the network and
RCCA Featured on MyCentralJersey
Cancer treatment network seeks to treat patients, control costs
we are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.